Viewing Study NCT02309320


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-01-29 @ 12:14 AM
Study NCT ID: NCT02309320
Status: COMPLETED
Last Update Posted: 2019-01-10
First Post: 2014-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171
Sponsor: Ablynx, a Sanofi company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-12
Start Date Type: ACTUAL
Primary Completion Date: 2016-02
Primary Completion Date Type: ACTUAL
Completion Date: 2016-02
Completion Date Type: ACTUAL
First Submit Date: 2014-11-27
First Submit QC Date: None
Study First Post Date: 2014-12-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-01-09
Last Update Post Date: 2019-01-10
Last Update Post Date Type: ACTUAL